Cogent Biosciences, Inc. Property, Plant and Equipment, Gross
Cogent Biosciences, Inc. (COGT) had Property, Plant and Equipment, Gross of $14.14 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-17
- 2025-12-31: Property, Plant and Equipment, Gross $14.14M.
- 2024-12-31: Property, Plant and Equipment, Gross $12.58M.
- 2023-12-31: Property, Plant and Equipment, Gross $12.01M.
- 2022-12-31: Property, Plant and Equipment, Gross $9.18M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $14.14M 10-K · filed 2026-02-17 |
| 2024-12-31 | $12.58M 10-K · filed 2026-02-17 |
| 2023-12-31 | $12.01M 10-K · filed 2025-02-25 |
| 2022-12-31 | $9.18M 10-K · filed 2024-02-26 |
| 2021-12-31 | $2.27M 10-K · filed 2023-03-14 |
| 2020-12-31 | $546.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | $6.50M 10-K · filed 2021-03-16 |
| 2018-12-31 | $6.75M 10-K · filed 2020-03-26 |
| 2017-12-31 | $6.29M 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |